Latest filing published 15 Sept 2026 for Theravance Biopharma, Inc., €196k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Rhonda Farnum: trading record in brief
This profile gathers the share dealings of Rhonda Farnum in Theravance Biopharma, Inc. Between 15 June 2026 and 15 September 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 15 September 2026, reports a transaction of €196k in Theravance Biopharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rhonda Farnum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,314 shares@ US$17.0342CommonSEC144:0001950047-26-009472
- 13,314 shares@ US$16.38630.024% mcap100.0% of flowCommonSEC144:0001950047-26-006154
2 of 2 declarations
